Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Ker

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Value in Health Regional Issues|November 3, 2022
Budget Impact Analysis of Empagliflozin in the Treatment of Patients With Type 2 Diabetes With Established Cardiovascular Disease in South AfricaJanetta Catharina de Beer, Jacques Snyman, James Ker, et al.
Current Medical Research and Opinion|April 21, 2011
Hypertension and its management in countries in Africa and the Middle East, with special reference to the place of β-blockadeM Samir Arnaout, Wael Almahmeed, Mohsen Ibrahim, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Value in Health Regional Issues|November 3, 2022
Budget Impact Analysis of Empagliflozin in the Treatment of Patients With Type 2 Diabetes With Established Cardiovascular Disease in South AfricaJanetta Catharina de Beer, Jacques Snyman, James Ker, et al.
Current Medical Research and Opinion|April 21, 2011
Hypertension and its management in countries in Africa and the Middle East, with special reference to the place of β-blockadeM Samir Arnaout, Wael Almahmeed, Mohsen Ibrahim, et al.
Pageof 3